PERSPECTA

News from every angle

← Back to headlines

Sagimet Biosciences Stock Climbs Amid Choppy Trading

Sagimet Biosciences shares rose 8% recently, navigating a period of volatile trading in the market.

4 Aug, 14:58 — 4 Aug, 14:58
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed2h ago

Sagimet Biosciences climbs 8% amid choppy trading in recent weeks

Read full article →

Related Stories

Irish Households Face Record Electricity Bill Arrears

17m ago

Athene Holding Reports Q2 GAAP EPS of $2.18 and $11.15B Revenue

18m ago

Duke Energy Targets $5B-$10B Capital Upside, Reaffirms EPS Growth Through 2030

20m ago

Wealthiest Americans Drive Majority of New Car Sales in the U.S.

22m ago